JPRN-UMIN000009614已完成未知
Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormality - Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event
Yokohama City University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2012年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects with a history of excessive alcohol consumption (>140 g/week for men, >70 g/week for women), other liver diseases, drug use associated with fatty liver, or weight reduction were excluded
研究者
相似试验
已完成
不适用
High intensity exercise for non-alcoholic steatohepatitis- is it safe, effective, and feasible in practice?Metabolic and Endocrine - Metabolic disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonnon-alcoholic steatohepatitisACTRN12616000305426The University of Queensland14
招募中
不适用
on-invasive diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease using markers and imaging techniquesfatty liver with inflammation10019654non-alcoholic steatohepatitisNL-OMON47211Medisch Universitair Ziekenhuis Maastricht110
招募中
不适用
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced FibrosisNonalcoholic SteatohepatitisNCT05720663Virginia Commonwealth University240
进行中（未招募）
不适用
PHYSIOPATHOLOGY OF NONALCOHOLIC HEPATIC STEATOSIS AND EFFICACY OF SILYMARIN IN THE THERAPY OF NONALCOHOLIC HEPATIC STEATOSISonalcoholic hepatic steatosisMedDRA version: 6.1Level: PTClassification code 10019708EUCTR2005-002966-12-ITTRASTEC100
招募中
不适用
A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing AtarNASHNCT06193629Shupei Li150